Загрузка...
Advances in autoimmune myasthenia gravis management
INTRODUCTION. Myasthenia gravis (MG) is an autoimmune neuromuscular disorder with no cure and conventional treatments limited by significant adverse effects and variable benefit. In the last decade, therapeutic development has expanded based on improved understanding of autoimmunity and financial in...
Сохранить в:
| Опубликовано в: : | Expert Rev Neurother |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6289049/ https://ncbi.nlm.nih.gov/pubmed/29932785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737175.2018.1491310 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|